282 related articles for article (PubMed ID: 22823000)
1. Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
Abshire TC; Federici AB; Alvárez MT; Bowen J; Carcao MD; Cox Gill J; Key NS; Kouides PA; Kurnik K; Lail AE; Leebeek FW; Makris M; Mannucci PM; Winikoff R; Berntorp E;
Haemophilia; 2013 Jan; 19(1):76-81. PubMed ID: 22823000
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of bleeding episodes in patients with von Willebrand's disease.
Federici AB
Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s26-32. PubMed ID: 19105507
[TBL] [Abstract][Full Text] [Related]
4. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
Holm E; Abshire TC; Bowen J; Álvarez MT; Bolton-Maggs P; Carcao M; Federici AB; Gill JC; Halimeh S; Kempton C; Key NS; Kouides P; Lail A; Landorph A; Leebeek F; Makris M; Mannucci P; Mauser-Bunschoten EP; Nugent D; Valentino LA; Winikoff R; Berntorp E
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):383-8. PubMed ID: 25688461
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis in von Willebrand disease.
Berntorp E
Haemophilia; 2008 Nov; 14 Suppl 5():47-53. PubMed ID: 18786010
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre study.
Dunkley S; Baker RI; Pidcock M; Price J; Seldon M; Smith M; Street A; Maher D; Barrese G; Stone C; Lloyd J
Haemophilia; 2010 Jul; 16(4):615-24. PubMed ID: 20331755
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score.
Federici AB; Barillari G; Zanon E; Mazzucconi MG; Musso R; Targhetta R; Mannucci PM
Haemophilia; 2010 Jan; 16(1):101-10. PubMed ID: 19811543
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease.
Hancock JM; Escobar MA
Expert Rev Hematol; 2023 Mar; 16(3):157-161. PubMed ID: 36861346
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.
Federici AB; Castaman G; Franchini M; Morfini M; Zanon E; Coppola A; Tagliaferri A; Boeri E; Mazzucconi MG; Rossetti G; Mannucci PM
Haematologica; 2007 Jul; 92(7):944-51. PubMed ID: 17606445
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience of prophylactic treatment in von Willebrand disease.
Lethagen S
Thromb Res; 2006; 118 Suppl 1():S9-11. PubMed ID: 16616322
[TBL] [Abstract][Full Text] [Related]
13. Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage.
Franchini M
Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s33-8. PubMed ID: 19105508
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis and von Willebrand's disease (vWD).
Abshire TC
Thromb Res; 2006; 118 Suppl 1():S3-7. PubMed ID: 16580053
[TBL] [Abstract][Full Text] [Related]
15. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
16. Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.
Holm E; Carlsson KS; Lövdahl S; Lail AE; Abshire TC; Berntorp E
Haemophilia; 2018 Jul; 24(4):628-633. PubMed ID: 29626372
[TBL] [Abstract][Full Text] [Related]
17. A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.
Peyvandi F; Castaman G; Gresele P; De Cristofaro R; Schinco P; Bertomoro A; Morfini M; Gamba G; Barillari G; Jiménez-Yuste V; Königs C; Iorio A; Federici AB
Blood Transfus; 2019 Sep; 17(5):391-398. PubMed ID: 30747707
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information.
Nowak-Göttl U; Krümpel A; Russo A; Jansen M
Haemophilia; 2013 Nov; 19(6):887-92. PubMed ID: 23919249
[TBL] [Abstract][Full Text] [Related]
19. The role of prophylaxis in the management of von Willebrand disease: today and tomorrow.
Abshire T
Thromb Res; 2009 Nov; 124 Suppl 1():S15-9. PubMed ID: 19944256
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand disease.
Berntorp E
Pediatr Blood Cancer; 2013; 60 Suppl 1():S34-6. PubMed ID: 23109385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]